|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 870.4 INR | -1.02% |
|
+4.13% | +0.18% |
| 05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
| 05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
Fredun Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 612.27 million compared to INR 481.25 million a year ago. Revenue was INR 620.46 million compared to INR 484.17 million a year ago.
Net income was INR 24.02 million compared to INR 9.44 million a year ago. Basic earnings per share from continuing operations was INR 5.24 compared to INR 2.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.18% | 49.5M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
FREDUN PHARMACEUTICALS LIMITED 
